Valneva Phase 2 data for Lyme disease vaccine candidate shows striking immune response
Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
Pfizer and Valneva have been collaborating on VLA15’s development and commercialization since April 2020
The fresh capital will propel Cordance into its first-in-human clinical trial
Renalyx will continue operating as an independent unit within the group
RK Pharma will manufacture and supply the finished product, while Zydus will be responsible for the NDA submission and commercialization of the product in the US
Owlet’s push comes as parents demand smarter, more dependable nursery tech
Jaypirca is making waves in the fight against B-cell malignancies
The Unit is approved by major regulators like EMA, Europe; Health Canada, Anvisa, Brazil and TGA, Australia
Gobivaz is authorised for adults with rheumatoid arthritis (in combination with methotrexate), psoriatic arthritis (with or without methotrexate), axial spondyloarthritis, and ulcerative colitis
The study successfully met its primary endpoint, demonstrating similar rates of viral suppression for DOR/ISL compared to Biktarvy at 48 weeks
Subscribe To Our Newsletter & Stay Updated